MedPath

Otsuka Pharmaceutical Factory, Inc.

Otsuka Pharmaceutical Factory, Inc. logo
🇺🇸United States
Ownership
Subsidiary
Established
1969-10-07
Employees
1K
Market Cap
-
Website
http://www.otsukakj.jp

Clinical Trials

13

Active:0
Completed:11

Trial Phases

2 Phases

Phase 1:2
Not Applicable:9

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials

Not Applicable
9 (81.8%)
Phase 1
2 (18.2%)

A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus

Phase 1
Recruiting
Conditions
Diabetes Mellitus, Type 1
Hypoglycemia
Islet Cell Transplantation
First Posted Date
2024-08-28
Last Posted Date
2025-08-06
Lead Sponsor
Otsuka Pharmaceutical Factory, Inc.
Target Recruit Count
13
Registration Number
NCT06575426
Locations
🇺🇸

University of Illinois Hospital &Health Scences System, Chicago, Illinois, United States

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Effect of NO-13065 in Healthy and Obese Adult Subjects

Phase 1
Completed
Conditions
Obesity
Interventions
Drug: Placebo
First Posted Date
2021-04-09
Last Posted Date
2023-11-02
Lead Sponsor
Otsuka Pharmaceutical Factory, Inc.
Target Recruit Count
84
Registration Number
NCT04838639
Locations
🇺🇸

Celerion, Lincoln, Nebraska, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.